UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 10, 2012

_______________________________

Hydromer, Inc.

(Exact name of registrant as specified in its charter)

_______________________________

New Jersey	001-31238	22-2303576
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

35 Industrial Parkway Branchburg, N.J. 08876
(Address of Principal Executive Offices) (Zip Code)

(908) 722 – 5000
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events

Press Release Announcing Hydromer, Inc. Entering Into Two Royalty Bearing Medical Coating Licenses in August 2012

EXHIBIT INDEX

Exhibit No.	Description of Exhibit

99.48	Press Release issued September 10, 2012

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

_______Hydromer, Inc._______
Registrant

_______/s/ Robert Y. Lee_______

Date September 12, 2012____

Robert Y. Lee
Chief Financial Officer

HYDROMER INC 8-K